Automobile and Powertrain Manufacturers to Provide Low-emission Technologies and Energy-efficient Platform Strategies

Technology joint ventures between suppliers and OEMs will be key to reduce compliance costs and boost sustainable growth opportunities, finds Frost & Sullivan’s Mobility team

London – April 19, 2017 – The global powertrain market is experiencing immense growth as new low-emission technologies such as engine downsizing and rightsizing; direct injection; turbocharging; transmission electrification; and electric vehicle (EV), hybrid and gasoline engines transform the industry. Original equipment manufacturers (OEMs) are embracing platform strategy as a tool to improve the energy efficiency of powertrain systems and to achieve fleet level CO2 compliance in a sustainable and cost efficient manner.

http://brn.firetrench.com

Continue reading

Looking Down The Corridors, Allied Aerial Espionage Over East Germany and Berlin 1945-1990

READ THE FULL REVIEW

The Cold War created threats and opportunities. An important story that has not been told is how the Allies used their access rights to Berlin to gather photo intelligence of Russian and East German activity. The authors have conducted thorough research into an area that has previously been hidden by classification of operations and images gathered, most recommended.


http://reviews.firetrench.com

http://adn.firetrench.com

http://brn.firetrench.com

http://ntn.firetrench.com

Altor BioScience and CMC Biologics Announce Agreement for Manufacture of Molecule ALT-803, for use in Phase 3 Clinical Trials

Altor BioScience and CMC Biologics Announce Agreement for Manufacture and Validation of Altor’s IL-15 Superagonist Molecule, ALT-803, for use in Phase 3 Clinical Trials

BOTHELL, Washington and MIRAMAR, Florida, U.S.A., April 13, 2017—CMC ICOS Biologics, Inc. (“CMC Biologics”), a global leader in clinical and commercial manufacturing of therapeutic proteins, and Altor BioScience Corporation (“Altor”), a leading developer of novel cytokine-based immunotherapeutics for cancer and infectious diseases, today announced that they have entered into a manufacturing agreement for the cGMP manufacturing of Altor’s ALT-803 molecule for use in Phase 3 clinical trials.

http://brn.firetrench.com

Continue reading

CHADWICK PREPARES FOR BRITISH F3 DEBUT THIS EASTER WEEKEND

– Former British GT4 Champion makes debut in British F3
– The UK’s leading single-seater category
– Oulton Park to host first 3 Rounds this Saturday and Monday
– Milestone in the career of the young, female racer

This weekend marks an important milestone for Jamie Chadwick as she embarks on her maiden single-seater campaign with Double R Racing in British Formula 3.

http://brn.firetrench.com

Continue reading

ELLIE GOULDING DRIVES NEW RANGE ROVER VELAR IN NEW YORK

  • Arrival of first Range Rover Velar in US announced by live performance from British pop superstar Ellie Goulding
  • Ellie drives fourth member of the Range Rover family ahead of its role in major fundraiser
  • Range Rover Velar auction at East Side House Settlement gala for New York education charity
  • Velar fills the space between the Range Rover Evoque and Range Rover Sport
  • Available to order from Land Rover retailers now priced from £44,830 / $49900, US deliveries begin late summer
  • Watch Ellie’s live performance: https://www.youtube.com/embed/oXDEqyl9WAQ
  • See Velar driven in New York by Ellie: https://youtu.be/C7LxuIHOwgg

http://brn.firetrench.com

Continue reading